Senior Director, Discovery Sciences

Slate Medicines

Raleigh (NC)

On-site

USD 260,000 - 380,000

Full time

46 hours ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Health Plan
401k
Life Insurance
Paid Time Off
Disability
Stock Options

Job summary

Slate Medicines seeks a senior leader to build a discovery organization focused on migraine biology and target validation. You will own in vitro and in vivo validation across multiple modalities, shaping go/no-go decisions and mentoring a high-performing team.

The role demands deep GPCR and ion channel expertise, modality-agnostic thinking, and a proven ability to drive programs from validation to clinical development with external-CRO oversight and scientific rigor.

Qualifications

  • PhD in pharmacology, cell/molecular biology, biochemistry, or a related discipline.
  • 12–15+ years of discovery research leadership in biotech or pharma, with the Executive Director level reserved for candidates with a broader and longer track record
  • Deep, hands-on GPCR and ion channel pharmacology experience, including receptor/channel subtype characterization and functional assays
  • Demonstrated, evidenced track record of personally moving at least one program from target validation through nonclinical toxicology into clinical development — named programs and outcomes, not oversight alone
  • Direct experience managing external CROs for in vitro and in vivo pharmacology, with accountability for data quality and timelines
  • Experience working across more than one therapeutic modality, or clear evidence of operating modality agnostically rather than being wedded to one
  • Demonstrated ability to build and lead a high-performing discovery organization with a reputation beyond the company itself

Responsibilities

  • Own in vitro and in vivo target validation strategy from early target hypothesis through development candidate (DC) nomination, including cell-based and animal models that establish target engagement, mechanism of action, and translatability to the clinic
  • Lead GPCR and ion channel pharmacology, including PACAP/VIP receptor biology (PAC1, VPAC1, VPAC2), and apply that expertise to new targets as the pipeline grows
  • Build and validate disease-relevant in vivo models, such as migraine pharmacology models, that produce decision-grade efficacy and mechanism data for go/no-go calls
  • Build a discovery function that isn’t tied to one modality: support biologics today and small molecules, peptides or other modalities as the pipeline expands, and partner with the CSO on choosing the right modality for each new target
  • Define discovery-to-development handoff criteria so programs enter nonclinical development with validated targets, characterized mechanism and de-risked biology
  • Lead programs from target validation through DC nomination and handoff to nonclinical toxicology, with personal accountability for scientific rigor and timelines
  • Select and manage the external CRO network, including overseas partners, for in vitro pharmacology, in vivo models, antibody/protein generation and cell line development, and hold them to Slate’s scientific standards and timelines
  • Lead discovery-stage scientific due diligence for in-licensing, collaboration and acquisition opportunities
  • Build and lead a discovery team known for scientific rigor and execution

Skills

GPCR pharmacology
Ion channel biology
Discovery leadership
CRO management
Multiple modalities
Target validation
Team leadership
In vivo models
Drug discovery strategy

Education

PhD in pharmacology, cell/molecular biology, biochemistry, or related discipline

Job description

About Slate Medicines

Slate Medicines is a clinical-stage biotech company developing next-generation therapeutics for migraine and other headache disorders. Its lead program, SLTE-1009, is a subcutaneous monoclonal antibody targeting both PACAP and VIP, with the potential to be a best-in-class option for migraine prevention; the program entered Phase 1 in 2026, with topline data expected in mid-2027 and a Phase 2 start planned for 2027.

Description
About Slate Medicines

Slate Medicines is a clinical-stage biotech company developing next-generation therapeutics for migraine and other headache disorders. Its lead program, SLTE-1009, is a subcutaneous monoclonal antibody targeting both PACAP and VIP, with the potential to be a best-in-class option for migraine prevention; the program entered Phase 1 in 2026, with topline data expected in mid-2027 and a Phase 2 start planned for 2027.

Slate is backed by leading healthcare investors including RA Capital Management, Forbion, Foresite Capital, and Frazier Life Sciences, and is on track to become a publicly traded company (Nasdaq: SLTE) through a planned merger with Fulcrum Therapeutics.

  • Own in vitro and in vivo target validation strategy from early target hypothesis through development candidate (DC) nomination, including cell-based and animal models that establish target engagement, mechanism of action, and translatability to the clinic
  • Lead GPCR and ion channel pharmacology, including PACAP/VIP receptor biology (PAC1, VPAC1, VPAC2), and apply that expertise to new targets as the pipeline grows
  • Build and validate disease-relevant in vivo models, such as migraine pharmacology models, that produce decision-grade efficacy and mechanism data for go/no-go calls
  • Build a discovery function that isn’t tied to one modality: support biologics today and small molecules, peptides or other modalities as the pipeline expands, and partner with the CSO on choosing the right modality for each new target
  • Define discovery-to-development handoff criteria so programs enter nonclinical development with validated targets, characterized mechanism and de-risked biology
  • Lead programs from target validation through DC nomination and handoff to nonclinical toxicology, with personal accountability for scientific rigor and timelines
  • Select and manage the external CRO network, including overseas partners, for in vitro pharmacology, in vivo models, antibody/protein generation and cell line development, and hold them to Slate’s scientific standards and timelines
  • Lead discovery-stage scientific due diligence for in-licensing, collaboration and acquisition opportunities
  • Build and lead a discovery team known for scientific rigor and execution
Requirements
  • PhD in pharmacology, cell/molecular biology, biochemistry, or a related discipline
  • 12–15+ years of discovery research leadership in biotech or pharma, with the Executive Director level reserved for candidates with a broader and longer track record
  • Deep, hands-on GPCR and ion channel pharmacology experience, including receptor/channel subtype characterization and functional assays
  • Demonstrated, evidenced track record of personally moving at least one program from target validation through nonclinical toxicology into clinical development — named programs and outcomes, not oversight alone
  • Direct experience managing external CROs for in vitro and in vivo pharmacology, with accountability for data quality and timelines
  • Experience working across more than one therapeutic modality, or clear evidence of operating modality agnostically rather than being wedded to one
  • Demonstrated ability to build and lead a high-performing discovery organization with a reputation beyond the company itself
Preferred Qualifications
  • Neurology, migraine, or headache disorder discovery experience
  • Direct antibody discovery/engineering experience (e.g., phage display, hybridoma, humanization) in addition to small-molecule or peptide discovery
  • Experience building a discovery function from an early- or growth-stage biotech, including standing up processes and vendor networks from a lean starting point
  • Experience designing cross-functional discovery-to-nonclinical-to-clinical handoff processes
  • Experience with both CNS-penetrant and peripherally restricted therapeutic strategies
Benefits
  • Health Care Plan (Medical, Dental & Vision)
  • Retirement Plan (401k, IRA)
  • Life Insurance (Basic, Voluntary & AD&D)
  • Paid Time Off (Vacation, Sick & Public Holidays)
  • Short Term & Long Term Disability
  • Stock Option Plan
Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

General Counsel
General Counsel

Slate Medicines • Raleigh (NC)

On-site
USD 180,000 - 250,000
Health Care Plan
401k plan
Life Insurance
+5
Senior Director, Discovery Sciences — GPCR & Migraine Programs
Senior Director, Discovery Sciences — GPCR & Migraine Programs

Slate Medicines • Raleigh (NC)

On-site
USD 260,000 - 380,000
Health Plan
401k
Life Insurance
+3
Executive Director/Vice President, Medical Lead
Executive Director/Vice President, Medical Lead

Crescent Biopharma , Inc. • Waltham (MA)

On-site
USD 330,000 - 365,000
Competitive salary
Performance bonus
100% employer-paid benefits
+2
Senior Manager/Associate Director, Nonclinical Study Management
Senior Manager/Associate Director, Nonclinical Study Management

Scribe Therapeutics • Alameda (CA)

On-site
USD 140,000 - 230,000
Health benefits
Equity
Wellness stipend
SVP of Clinical Development Pain
SVP of Clinical Development Pain

Noema Pharma • Boston (KY)

On-site
USD 200,000 - 300,000
Executive Director / Vice President, Discovery / Research
Executive Director / Vice President, Discovery / Research

Work In Biotech • Seattle (WA)

Hybrid
USD 250,000 - 420,000
Director, Head of Drug Discovery
Director, Head of Drug Discovery

ADP, Inc. • San Diego (CA)

On-site
USD 191,000 - 250,000
Employee Stock Purchase Program (ESPP)
Equity via Stock Options
Health benefits
+1
Scientific Director, Lead Generation Biology
Scientific Director, Lead Generation Biology

Neurocrine Biosciences • San Diego (CA)

On-site
USD 188,700 - 257,000
Retirement plan with company match
Paid vacation
VP of Discovery Biology
VP of Discovery Biology

Gordian Biotechnology • South San Francisco (CA)

On-site
USD 230,000 - 300,000
Equity stake
Competitive salary
Health insurance
+5
Vice President or Senior Vice President, Head, Drug Discovery & Biology
Vice President or Senior Vice President, Head, Drug Discovery & Biology

Integratedcooling • Watertown (MA)

On-site
USD 350,000 - 520,000